Furthermore, three reports (51–53) showed that in KRAS-driven cancers such as pancreatic cancer, RAF/MEK/ERK kinase cascade and the autophagy pathways cooperate to maintain tumor survival and, as such, the combined inhibition of both pathways was highly efficacious at inhibiting tumor growth. The gene discussed is MAP2K7; the disease is pancreatic neoplasm.